Press Releases
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
Organic revenue growth1 of 4% driven by Care Enablement and Care DeliveryUnderlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full yearAccumulated savings of
